Introduction
An association between arteriovenous malformations of the face, retina and brain was first recognized by Bonnet, Dechaume and Blanc 3 in 1937 and Wyburn-Mason 4 in 1943. This rare disease encompasses a spectrum of phenotypic expression which is likely to share anembryonic developmental defect, as well as their names, Bonnet-Dechaume-Blanc and Wyburn-Mason syndrome.
Clinical Course and Angioarchitecture of Cerebrofacial Arteriovenous Metameric Syndromes
Three Demonstrative Cases and Literature Review Figure 1 A) CECT scan of the orbits since september 1984 showed enhancement and enlargement of the left optic nerve indicating AVMs, inverted picture. B) MRI brain sagittal T1W since september 1988 showed minimal extension of AVMs along right hypothalamus and thalamus. C) MRI brain in 1999 showed progression of the AVMs nidus, involving the left hypothalamus and anterior thalamus in a progressive fashion. D) Cerebral angiogram in 2000, left facial artery injection showed a small AVMs involving the nasal tip fed by the distal branch of the labial artery with two proximal arterial aneurysms of facial artery within left submandibular region. nerve of the left eye, confirmed by fluoroscein angiogram, in 1979. He has no supportive history of familial hereditary hemorrhagic telangiectasia.
CT brain and orbits in 1984, showed the AVM had extended posteriorly into left optic nerve and involved the suprasellar area ( figure 1A) . without neurological deficit or intracranial hemorrhagic event.
In 1990, there was a small red spot, diagnosed as angioma on the tip of his nose, which remained stable until 1992. The angioma began to increase in size and continued to grow until 1996 when it stabilized again.
The most recent MRI in 1999, clearly defined the midline AVMs involving the optic chiasm, more on the left side, continuing with the cerebral AVMs involving the left hypothalamus and anterior thalamus. Venous drainage was into an enlarged left basal vein of Rosenthal, which appeared to progress in size with extension of the AVMs and increased shunt flow (figure 1), compared with a previous study.
The patient requested medical treatment for cosmetic reasons because of the enlarging vascular lesion on the tip of his nose.
Recent cerebral angiogram in 2000, for therapeutic purposes revealed two AVMsin different locations, one involving the nasal tip and one in the palate. Arterial feeders were branches of the left maxillary and facial artery (figures 1C,D). There was a large aneurysm at the distal left maxillary artery, sitting in the left pterygopalatine fossa, and another two aneurysms of the facial artery in the left submandibular region.
The intracranial AVM nidus was fed by numerous, smoke-like, perforating branches of the bilateral anterior choroidal arteries, lentriculostriate arteries, left ophthalmic artery, and small feeders from choroidal branches of the left posterior cerebral artery (figures 1E,F). The draining veins of the intracranial AVMs were mainly the left basal vein of Rosenthal and smaller left thalamostriate vein, whereas the intraorbital lesion drained via the left ophthalmic vein and cavernous sinus respectively. No evidence of flow-related aneurysm or venous ectasia or other indication of high flow lesion was observed. The brain drained normally.
The aneurysm in the left pterygopalatine fossa was treated first, due to the risk of severe epistaxis. The aneurysm was successfully embolized with GDC detachable coils (figure 1G).
The AVM at the nasal tip was treated by preoperative embolization with polyvinyl alcohol particles into the left facial artery, left transverse facial artery, left maxillary artery, followed by proximal spongel embolization into the right facial artery and left transverse facial artery successfully, prior to plastic surgery.
Treatment of the intracranial lesion was considered too hazardous and conservative management was decided unless the patient develops neurological symptoms in the future.
Case II
The second patient is a four-year-old boy, born in june 1993. He suffered from severe headache followed by hemiconvulsion on the right side several hours later. Physical examination revealed right side hemiparesis and hemianopsia. CT brain scan showed a small hematoma in the left occipital lobe ( figure 1A) . Concomitant MRI and cerebral angiogram re-vealed a multifocal fine AVMs nidus extending from the proximal left optic nerve to the left inferior hypothalamus and calcarine fissure, compatible with the diagnosis of Wyburn-Mason syndrome (figures 2B,C). Cerebral angiogram revealed a large cerebral AVM fed by perforating branches from the left anterior choroidal artery, left ophthalmic artery, lentriculostriate artery and calcarine branch or left posterior cerebral artery (figure 2D,E).
The patient successfully underwent endovascular embolization with N-Butyl Cyanoacrylate (NBCA) in june 1997. On follow-up, he had mild right hemiparesis with mild speech and language disorder. He occasionally develops focal seizures associated with high fever, controllable by anticonvulsants.
He suffered from progressive neurological complaints of right hemiparesis, right hemianopsia, dysphasia and headache in 1999-2001, despite another session of partial embolization in june 1999. Recent MRI showed progressive extension of the AVMs nidus and control angiogram revealed significant increased size of the AVM, with enlargement of the draining vein via left thalamostriate vein and left occipital lobe vein, indicating a progressive increase in shunt flow through the AVMs (figure 2F,H).
The lesion was considered. The therapeutic goal was to stabilise the AVM by partial embolization.
Case III
The third patient is the second son of healthy non consanguineous parents, born in August 1990. He attended school normally despite episodes of nose bleeding. At the age of five years and seven months, he developed sudden headache and unconciousnesswhich he spontaneously recovered. At the age of six years, the teacher in primary school noticed that he had visual disturbance. Ophthalmological examination revealed right eye blindness with marked dilated vessels covering the optic disc. First MRI in 1996 showed a large AVM with extensive involvement of the right optic nerve to the optic chiasm and hypothalamic area to the right temporal lobe, thalamus, insular lobe and parieto-occipital lobe and paracalcarine lobules (figures 3A,B). No evidence of intracranial haemorrhage was detected.
Cerebral angiogram in april 1997 showed a large cerebral AVM with fine nidus, involving the right optic nerve and chiasm, hypothalamus and thalamus, fed by the right ophthalmic artery, perforating branches of the anterior choroidal artery and around the circle of Willis. The lesions in the right parieto-occipital lobe and calcarine fissure were fed by the right pos- 
Discussion
Our first case clearly showed the sequence of presenting symptoms which corresponded to the full spectrum of CAMS expression. He initially presented with retinal and optic nerve AVMs at an early age (7 years), leading to investigation and discovery at the asymptomatic cerebral AVMs at 12 years of age. The intracranial lesion appeared to grow during the followup period even though he remained asymptomatic. Progressive growth of the facial lesion made the patient seek treatment. Investigations revealed at 18 years of age, nasal AVMs of the nasal tip, leading to therapeutic endovascular approach followed by plastic surgery for cosmetic correction of the nasal lesion. There were coexisting asymptomatic palatine AVMs and proximal arterial dysplastic aneurysms, with potential risk of life-threatening epistaxis, leading to therapeutic endovascular approach.
The second case showed the progression in size and shunt flow of intracranial AVMs in a CAMS patient presenting with intracranial haemorrhage, despite partial endovascular treatment. This case supports the fact that the intracranial expression is an ongoing active process beginning from the discovery of the first revealing symptoms until it reaches maturation or remains unchanged on long-term follow-up.
The third case is another example of sequential disclosure of symptoms from visual disturbance since early childhood (6 years old) resulting from right optic nerve and retinal AVMs, and concomitant cerebral AVMs, discovered one year later. These have caused progressive neurological deficit and brain parenchymal damage during a two year followup, even without evidence of intracranial haemorrhage. Hence haemodynamic insult to brain parenchyma can be severe even without a hemorrhagic event in CAMs patients.
By clinical observation from our cases and review of the literature, we propose the natural history of CAMS in terms of revealing clinical expression of intracranial and extracranial lesions, including time and age at presentation, clinical consequences, angioarchitecture and fate of each separate lesion.
Natural History of CAMS Incidence of CAMS
This metameric syndrome is considered a rare disease entity and was first recognized by-Bonnet, Dechume and Blanc who reported two cases in 1937. An additional nine cases were reported by Wyburn Mason in 1943, and a new larger series of 15 cases by Bhattacharya in 2001, who introduced a new nomenclature of the disease: Cerebrofacial Arteriovenous Metameric Syndrome (CAMS). There were also scattered reported cases of this disease spectrum occasionally from all over the world and some reported cases in the ophthalmological literature.
In one series of 203 patients by Willinsky 12 with cerebrovascular malformations, 18 (9%) patients had multiple AVMs Among these, there were five patients with Rendu-Osler-Weber, one (0.5%) with Wyburn-Mason syndrome and two with concurrent AVMs and the remaining 10 (4%) patients had multiple brain AVMs. Even though considered a rare disease, we believe that the true incidence of CAMS is still underestimated and obscured in groups of sporadic cerebral AVMs or retino-facial malformation with increased clinical suspicion of this disease entity. Careful angiographic study and other investigations such as CT or MRI of the craniofacial region, and detailed ophthalmologic study would be helpful to discover this rare disease.
Age at Clinical Presentation
Bhattacharya observed that the age at presentation of the patients with CAMS is much younger than in sporadic AVMs. Because CAMS is considered a defect of the neural crest cell from the head and pharyngeal arch which occurs in the early embryonic period 1 , so it seems to be true that the earlier the occurrence of the defect, the earlier the revealing symptoms appear.
This conclusion would be true when comparing the age of each patient, but on the other hand, it may not always be true when comparing the lesions separately. CAMS being a spectrum of phenotypic expressions, involving a wide area from intracranial location to extracranial facial expression. For example, the hypothalamus and nasal lesion in CAMS 1, occipital lobe, thalamus and maxilla in CAMS 2, or cerebellum, pons and mandible in CAMS 3 or even mixed phenotypical expressions all have their own natural history and presenting symptoms. So another reason for the younger age at presentation in CAMS could be the mixture between varied presenting symptoms leading to early detection of the syndrome. Careful observation of the coexisting lesions in CAMS patients separately is a better way to understand the natural history of these lesions, despite the fact that the lesion in the same location or organ of involvement for CAMS may contain different expression and angioarchitecture compared to sporadic cases as well.
There appears to be no significant sex predilection for CAMS patients in the literature 1 (table 1) .
Clinical Presentation of CAMS Patient
In the literature review, the clinical presentation of patients with CAMS varies according to the spectrum of organ involvement in this metameric disease. But in general, the commonest presenting symptoms of the reported cases include progressive visual loss, followed by neurological deficit with or without hemorrhagic event, and rarely seizures 1 .
Associated facial vascular malformations are considered uncommon, even though frequent minor epistaxis is one of the common observation in CAMS patients, despite the lack of nasal pathology not being detected by angiography or other investigations. Clinical bias by other questions regardless of a more common disease, Rendu-Osler-Weber, may be responsible for this confounding factor of clinical minor epistaxis in childhood.
A summary of reviewed literature on the reported cases is attached in table 1.
Clinical presentation for different pathological expression in different location and natural history with specific findings, as well as suggestions for investigation and treatment are described as follows.
Retinal AVMs and AVMs Along Optic Nerve and Chiasm
Retinal AVMs were present in most CAMS patients but there were six reported cases without retinal involvement in published literature 1, 8, 13 . We found nine out of 14 patients with retinal AVMs in our review. Therefore we sug-gest a more detailed screening test which includes ophthalmologic examination with visual field testing, visual acuity and fluorescein angiography, for patients suspected to have CAMS disease.
Progressive visual loss including decreased visual acuity and visual field defect seem to be the earliest presenting symptoms of CAMS disease, which usually present several years before the discovery of the retinal lesion. It usually occurs in childhood or younger patients, as in nine out of 14 cases in our review including our first and third cases. Bhattacharya showed 9/15 cases of CAMS who presented with visual symptoms in his report 1 with a mean age 17.4 years. A few other reported cases with symptomatic retinal lesions were included in table 1.
The retinal arteriovenous malformation or arteriovenous communications of the retina (AVCR) or so-called racemose haemangioma in ophthalmological literature, is probably a misnomer because it does not exhibit proliferative or tumor behavior. According to Archer's classification, grade III AVCR is the most severe form, and is often linked with an intracranial lesion or CAMS 14 .
Retinal AVMs or AVCR are usually considered stable retinal lesions, despite progression of the coexisting intracranial AVMs 15 . Clinical presentations of this lesion include loss of vision due to intraretinal macular haemorrhage, central and peripheral retinal vein occlusion, and vitreous haemorrhage, or even gradual reduction of vision due to neovascular glaucoma in association with changes in the retinal AVMs and retinal and choroidal ischemia 5 .
From the therapeutic aspect, it was well established that retinal AVMs were considered incurable, despite the appearance of nonchanging congenital vascular anomalies or socalled racemose angiomas of the retina. There is a reported case of retinal AVM, changing in size, on long-term follow-up of 17 years.
Optic nerve and chiasmal AVM is also a hallmark finding in CAMS. It appears to be clinically silent due to its slow progressive functional deficit. The presenting symptoms include decreased visual acuity and field defect, or blindness from optic nerve atrophy and progressive dysfunction of the optic pathways. Pathophysiologically resulting from chronic congestive venous drainage or steal phenomenon from the AVMs 6,7 . Exophthalmos is a rare presenting symptom in CAMS; with optic nerve AVMs and intraorbital congestion resulting in mass effect as reported by Fujita 7 , Muthukumar 16 and our third case. Exophthalmos could result from an enlarged ophthalmic vein, which provides drainage of normal brain tissue or even cerebral AVMs due to increased intracranial venous pressure caused by venous occlusion of draining veins.
Treatment of these orbital lesions remains a challenge because of the complex anatomic and hemorrhagic characteristics of the malformation.
Attempts to treat these patients with combined surgery and careful preoperative embolization are not without risk, but offer an important advantage in the treatment of these formidable lesions, as reported by Goldberg RA 17 in two cases of the intraorbital AVMs. There was consequent visual field defect from partial emboli in the central retinal artery and spasm of the ophthalmic artery in their reported cases which resolved spontaneously. 
Cerebral AVMs
Considered metameric lesions, intracranial AVMs in CAMS are one of the most common findings in such patients. We found cerebral AVMs in 11 out of our 14 reviewed cases. According to Bhattacharya, the cerebral AVMs in CAMS could evolve continuously from the optic chiasm, hypothalamus, thalamus and cortical lesion around the calcarine fissure or even cerebellum depending on the I, II or III subtype of CAMS, mostly presenting in contiguous scattered fashion; but could infrequently present as isolated multiple lesions.
Considering the angioarchitecture of cerebral AVMs in CAMS, we observed that there were a few common findings of cerebral AVMs in CAMS, which differs from sporadic AVMs. For example, AVM nidi in CAMS patient are usually described as a cluster or bunch of smoke-like, small fine nidi intervening with normal brain tissue and optic pathways with some degree of angiogenesis. A transdural arterial supply was present in some cases; and interestingly there were no reported cases of high flow arteriovenous fistula (AVFs) or related findings of high flow shunt such as dysplastic flow-related arterial aneurysm or huge dilated draining veins, as we usually see in other inborn diseases, such as Hereditary Hemorrhagic Telangiectasia (Rendu-Osler-Weber disease). Hence the fact that the different embryonic pathophysiology of these two diseases could express the different angioarchitecture of the cerebral AVMs, followed by different risk and natural history.
Progressive enlargement of cerebral AVMs is one of the special observations in CAMS, as demonstrated in our second case. Yasuhara 18 also reported a similar case with a progressive increase in size and shunt flow of the cerebral AVM with deterioration of neurological deficit. These findings support the fact that angiodysplasia in metameric syndrome is not static but an ongoing process.
Multifocality and the continuing fashion of disease expression are also well known features of cerebral AVMs in CAMS, with the lesions along the optic pathway. Usually lesions are localized in one hemisphere, but there are a few reports of bilateral involvement, crossing the midline. Two possibilities of this event are: angiogenesis crossing the midline could be due to related ischemia of the midline structures such as chiasmatic or hypothalamic AVMs; another possibility is that inter metameric cephalic neural crest migration may not be restricted to their own region, as previously described for mixed phenotypic expression between different adjacent rhombomeres 1 .
Despite the common presentation of cerebral AVMs in CAMS, they are usually clinically silent or asymptomatic at the time of discovery, but they could sometimes present as acute neurological symptoms from intracerebral haemorrhage or subarachnoid haemorrhage 1 or infrequently present with progressive neurological deterioration without any evidence of intracranial bleeding as in our third case.
Because of its rarity, we probably discover it only when they have presenting symptoms related to referring specialities.This could probably lead to an overestimation of the incidence of neurological events in CAMS disease. JJ Bhattacharya reported four cases of intracerebral haemorrhage and nine cases with neurological symptoms out of 15 CAMS patients. Whereas nine out of our 14 reviewed CAMS patients including ophthalmological literature were asymptomatic at the time of discovery of the cerebral lesion (table 1) .
Management of the cerebral AVMs and AVMs along the optic pathways related to CAMS is particularly challenging as the disease was considered incurable. In one series of six patients with Wyburn-Mason disease, managed by endovascular treatment, two became blind 2 . We suggest targetted embolization in an attempt to stabilize the lesion at the weak point or hemorrhagic portion, which carries angiographic risk, or in seriously symptomatic patients.
Facial AVMs, Nasal AVMs and Mandibular AVMs
Facial AVMs and mandibular AVMs are hallmarks of Bonnet-Dechaume-Blanc disease, recently called CAMs disease. The full spectrum of one syndrome was present in five out of 14 cases in our review (table 1) and Bhattacharya 1 found four out of 15 facial AVMs in his report. Presentation of facial lesions could be obscured or clinically silent, sometimes presenting as a small stable red spot or angioma for years, since infancy and childhood, as in our first case. Then an unknown trigger promoting growth of the lesion or clinical revealing symptoms such as bleeding of the gums, mass effect resulting in facial asymmetry, will clinically present in adolescence.
The angioarchitecture of facial or mandibular AVMs in CAMS is not significantly different from the sporadic cases. We do observe that they usually present as an arteriovenous fistula or nidus-typed arteriovenous malformation with fistulous feeder.
Another interesting finding is that there is a large proximal arterial aneurysm formation despite slow flow or small facial or mandibular AVMs, as seen in Case I. This finding supports the dysplastic origin of the aneurysm rather than haemodynamic stress from high flow fistula, and also supports the metameric basis of the disease involving structures having the same embryonic neural crest origin. This is probably the one distinguishing finding that alerts us in CAMS patients.
Obviously the facial AVMs and intracranial AVMs in CAMS patients are different in terms of angioarchitecture and natural history. The different expression of disease in different locations could be the result of a different migrational process in different pathways or because of different abluminal environment or even intercellular activity in these different locations, which need further study.
In our first demonstrated case, proximal unruptured arterial aneurysm in sphenopalatine fossa far away from the distal nasal AVMs alerted us to treat this patient on the basis of the anatomical risk of severe epistaxis. Mandibular AVMs with intraosseous venous lake or pouch is also at risk from severe bleeding after tooth extraction. In reviewed reports, there were usually minor epistaxis and bleeding gums in CAMS patients, without incidence of severe epistaxis or bleeding from intramandibular venous lake.
The hemorrhagic risk of facial and mandibular AVMs seems to be an angiographical risk rather than an incidental presentation. Even though there is one report of severe uncontrollable oral cavity bleeding in a seven-year-old girl with CAM S 15 , most of them are considered clinically silent and benign.
The therapeutic approach for facial AVMs does not depend only on angiographic risk for haemorrhage. Functional preservation, in cosmetic and reconstructive surgery are important factors when considering the patients'quality of life. A combined effort of endovascular therapy and reconstructive plastic surgery is recommended to achieve the therapeutic purposes is recommended in this situation.
Investigation for CAMS Patients
Proper investigations for patients suspected to have CAMS vary, due to different clinical manifestations and revealing lesions in their spectrum.
The patients suspected of CAMS 1 with hypothalamic AVMs should be investigated in detail for nasal AVMs and orbital AVMs by physical examination and detailed ophthalmological examination.
For CAMS 2, patients with mesencephalic lesions such as chiasmatic or optic nerve AVMs with progressive visual loss, should be investigated for maxillary vascular lesions including AVMs or metameric proximal dysplastic aneurysm within the nasal or pterygopalatine fossa. This could prevent life-threatening epistaxis from the asymptomatic aneurysm.
For CAMS 3, patients with cerebellar AVMs should be investigated for mandibular lesions such as high flow mandibular AVMs; those could lead to severe bleeding after tooth extraction in the adolescent.
On the other hand, patients presenting with facial vascular lesions with characteristic high flow AVFs or dysplastic aneurysm in the nasal area or mandibular AVFs should be investigated for possible coexisting asymptomatic intracranial AVMs. With currently available, high quality techniques of investigation, we recommend non-invasive investigation such as contrast-enhanced CT scan (CECT) 10 or MRI and MR angiography which give high specificity and negative predictive value. These investations can reveal nasal, maxillary, orbital, mandibular vascular malformations or even intracranial AVMs, considering the anatomical and developmental relationship of this metameric disease and giving the best outcome to our patients suffering from CAMS disease.
Conclusions
CAMS, a rare disease affecting the cerebrofacial area in the same metameric distribution, was newly introduced by Bhattacharya in terms of a new classification and diagnostic criteria.
We described our observations on the natural history of CAMS including the angioarchitecture and the fate of the lesions.
Retinal AVM was the most common finding frequently leading to the diagnosis of CAMS, usually presenting with early symptoms of visual failure in early childhood. This was easily diagnosed with detailed ophthalmological examination. Optic nerve and chiasmatic AVMs were almost all asymptomatic or presenting with slow progressive visual loss from congestion or ischemic events.
Cerebral AVM was a less common finding and usually asymptomatic at presentation, even though it could present as a hemorrhagic event or progressive neurological deficit without bleeding. The AVMs nidus in CAMS usually appears as a small fine, smoke-like lesion intermingled with normal brain tissue.
Treatment of retinal AVMs, optic nerve
AVMs and intracranial AVMs is controversial and at risk of acute blindness or field defect.
Facial and mandibular AVMs had almost the same natural history of sporadic cases in terms of revealing time in adolescence, but they usually contain some direct fistulae inside the lesion and also proximal large dysplastic arterial aneurysm, unrelated to the AVFs shunt flow which is unique for this metameric disease.
We suggest detailed ophthalmologic investigation as a sensitive screening test for suspected cases of CAMS. Patients who present with some specific location should be investigated for another lesion in the same metameric origin to prevent the patient from the life-threatening risk of severe epistaxis or bleeding gums after tooth extraction. CECT played an important role in this screening test in CAMS.
